NCT07409116

Brief Summary

To determine the added value of integrating virtual reality therapy (VRT) based balance training into conventional therapy (CT) for improving balance and gait in subacute stroke patients, and to evaluate the usability and patient satisfaction associated with the VRT based intervention, stroke patients will be recruited in the Neurorehabilitation Department of Erasme University Hospital. Patients will be randomized to a group performing only CT (CT group) and a group in which 20% of the daily CT was replaced by VRT involving standing balance exercises performed with an immersive headset (VRT group). Functional ambulation classification (FAC), gait speed and step length on 10 meters walking test (10MWT), walking distance on 2 minutes walking test (2MWT) and Berg Balance Scale (BBS) will be assessed at baseline (T0) and post-intervention (T1). Sensory reweighting in the VRT group will also be evaluated through the Sensory Organization Test (SOT) at T0 and T1. Usability of the VR system and patient satisfaction associated with virtual reality will be assessed at T1 in the VRT group through a questionary.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 8, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 10, 2025

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

January 30, 2026

Completed
14 days until next milestone

First Posted

Study publicly available on registry

February 13, 2026

Completed
Last Updated

February 13, 2026

Status Verified

January 1, 2026

Enrollment Period

1.2 years

First QC Date

January 30, 2026

Last Update Submit

February 6, 2026

Conditions

Keywords

strokerehabilitationbalancegaitvirtual reality

Outcome Measures

Primary Outcomes (1)

  • Change in Balance Performance from Baseline to Post-Intervention

    To address this objective, the Berg Balance Scale (0-56 points; higher scores indicate better balance) will be used to assess changes in functional balance performance from baseline to post-intervention.

    From enrollment to the end of treatment at 2 weeks

Secondary Outcomes (1)

  • Change in Sensory Contributions to Postural Control measured by the Sensory Organization Test (SOT).

    From enrollment to the end of treatment at 2 weeks

Other Outcomes (4)

  • Patient-Reported Satisfaction and Acceptability of Virtual Reality Training at Post-Intervention

    1 questionnaire at the end of treatment at 2 weeks

  • Change in Functional Ambulation Classification (FAC) Score

    From enrollment to the end of treatment at 2 weeks

  • Change in Walking Endurance Measured by the 2-Minute Walk Test (2MWT)

    From enrollment to the end of treatment at 2 weeks

  • +1 more other outcomes

Study Arms (2)

Conventional Therapy (CT)

ACTIVE COMPARATOR

conventional therapy will focus on motor rehabilitation, individualized according to their specific functional needs (exercises for individual deficits and mainly comprised sit-to-stand transfers, balance exercises, walking independence exercises, ergocycle endurance exercises, and dual-task exercises)

Other: Standard Conventional Rehabilitation

Virtual Reality Therapy-Based Rehabilitation (VRT)

EXPERIMENTAL

This group will benefit from integrating virtual reality therapy (VRT) based balance training into conventional therapy (CT). Conventional therapy will be partially replaced by VRT (20% of the total weekly rehabilitation time over a 2-week period corresponding in five 20-minute segments each week, resulting in a total of 10 VRT sessions) in such a way that the overall daily duration of motor rehabilitation will be equivalent between the VRT and CT groups.

Other: Virtual Reality Rehabilitation Program

Interventions

Conventional Therapy will focus on motor rehabilitation, individualized according to their specific functional needs (exercises for individual deficits and mainly comprised sit-to-stand transfers, balance exercises, walking independence exercises, ergocycle endurance exercises, and dual-task exercises)

Conventional Therapy (CT)

The virtual reality system will consist of a fixed computer running Virtualis software (Virtualis, France) an HMD (HTC Vive, HTC, Taiwan) with a resolution of 2,160 × 1,200 pixels (Full HD), a horizontal field of view of 110◦ and a frame rate of 90 Hz, two portable controllers (Vive Controller, HTC, Taiwan) and two static force platforms designed to measure center of pressure (CoP) data synchronized with the immersive virtual environments. Each session will last 20 minutes and will be performed under therapist supervision The VR training will consist of different types of exercises: 1/ weight transfer exercises (e.g. skiing) 2/ scrolling exercises (e.g. scrolling in a tunnel); 3/ dual-task exercises (balance + fun upper limb exercises) and 4/ stability limit exercises.

Virtual Reality Therapy-Based Rehabilitation (VRT)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Hemorrhagic or ischemic stroke within the past 6 months,
  • Minimum age of 18 years old,
  • Ability to stand and walk with or without assistance
  • Mini-Mental State Examination score of more than 15/30
  • Ability to understand instructions,
  • No visual deficits hindering VR training and vi) a health status allowing for rehabilitation

You may not qualify if:

  • other orthopedic or neurological disease altering the function of the paretic lower limb, balance or gait.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Erasme University Hospital (Hôpital Universitaire de Bruxelles - H.U.B.)

Brussels, 1070, Belgium

Location

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Chloé Sauvage, PhD

    Université Libre de Bruxelles

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This study will be a pragmatic, randomized controlled trial conducted in routine clinical settings
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 30, 2026

First Posted

February 13, 2026

Study Start

January 8, 2024

Primary Completion

March 30, 2025

Study Completion

May 10, 2025

Last Updated

February 13, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations